1. EMA. Summary of opinion (initial authorisation). Eklira Genuair: aclidinium bromide. European Medicines Agency, Committee for Medicinal Products for Human Use; May 24, 2012. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002211/WC500127779.pdf. Accessed February 3, 2014.
2. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). Global Initiative for Chronic Obstructive Lung Disease; 2020. Available from: http://goldcopd.org/gold-reports/. Accessed April 01, 2019.
3. Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark
4. Comparative Safety of Long-Acting Inhaled Bronchodilators
5. A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD